{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:44:37Z","timestamp":1768322677165,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T00:00:00Z","timestamp":1551312000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12884-019-2228-4","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T05:04:33Z","timestamp":1551330273000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Option B plus antiretroviral therapy adherence and associated factors among HIV positive pregnant women in Southern Ethiopia"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3831-5465","authenticated-orcid":false,"given":"Dawit Jember","family":"Tesfaye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desalegn Tsegaw","family":"Hibistu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teshome Abuka","family":"Abebo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feleke Tafesse","family":"Asfaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaleegziabher","family":"Lukas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tariku","family":"Laelago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ermias Abera","family":"Turuse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henok Gebreyohaness","family":"Kebede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham Abate","family":"Altaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanuel Belayneh","family":"Bekele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,28]]},"reference":[{"key":"2228_CR1","unstructured":"World Health Organization (WHO). 'Mother-to-child transmission of HIV'. \n                    http:\/\/www.who.int\/hiv\/topics\/mtct\/about\/en\/\n                    \n                   , accessed 15 Sep. 2017."},{"key":"2228_CR2","volume-title":"Recommendations for a public health approach","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. In: Recommendations for a public health approach. Geneva: WHO; 2010."},{"key":"2228_CR3","unstructured":"World Health Organization. HIV\/AIDS programme. Use of antiretrovoral drugs for treating pregnant women and preventing HIV infection in infants. 2012. \n                    http:\/\/www.who.int\/hiv\/PMTCT_update.pdf\n                    \n                  ."},{"key":"2228_CR4","unstructured":"Joint United Nations Program on HIV\/AIDS (UNAIDS). Prevention gap report. 2016."},{"key":"2228_CR5","unstructured":"Joint United Nations Programme on HIV\/AIDS. Children and HIV fact sheet. 2016."},{"key":"2228_CR6","volume-title":"National comprehensive PMTCT\/MNCH\/RH training package guideline reference manual","author":"Federal Ministry of Health","year":"2013","unstructured":"Federal Ministry of Health. National comprehensive PMTCT\/MNCH\/RH training package guideline reference manual. Addis Ababa: FMOH; 2013."},{"issue":"5","key":"2228_CR7","doi-asserted-by":"publisher","first-page":"431","DOI":"10.11648\/j.sjph.20140205.19","volume":"2","author":"T Tadele","year":"2014","unstructured":"Tadele T, Tamiso A, Tadele T. Incidences and predictors of HIV positivity among infants who born from HIV positive mother who have follow up at two hospitals of southern Ethiopia. Sci J Public Health. 2014;2(5):431\u20139.","journal-title":"Sci J Public Health"},{"key":"2228_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.7326\/0003-4819-133-1-200007040-00004","volume":"133","author":"DL Paterson","year":"2000","unstructured":"Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, Wagener MM, Singh N. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21\u201330.","journal-title":"Ann Intern Med"},{"key":"2228_CR9","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1097\/00002030-200111090-00006","volume":"15","author":"R Gross","year":"2001","unstructured":"Gross R, Bilker W, Friedman H, Strom B. Effect of adherence to newly initiated antiretroviral therapy on plasma viral load. AIDS. 2001;15:2109\u201317.","journal-title":"AIDS"},{"key":"2228_CR10","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1056\/NEJM199908053410602","volume":"341","author":"P Garcia","year":"1999","unstructured":"Garcia P, Kalish L, Pitt J, Minkoff H, Quinn T, Burchett S, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. N Engl J Med. 1999;341:394\u2013402.","journal-title":"N Engl J Med"},{"key":"2228_CR11","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1098\/rspb.2005.3352","volume":"273","author":"R Smith","year":"2006","unstructured":"Smith R. Adherence to antiretroviral HIV drugs: how many doses can you miss before resistance emerges? Proc Biol Sci. 2006;273:617\u201324.","journal-title":"Proc Biol Sci"},{"key":"2228_CR12","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/01.qai.0000182229.84182.06","volume":"40","author":"E Gardner","year":"2005","unstructured":"Gardner E, Burman W, Maravi M, Davidson A. Settings towards universal access: recommendations for a selective drug taking during combination antiretroviral therapy in an unselected clinic population. J Acquir Immune Defic Syndr. 2005;40:294\u2013300.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 2","key":"2228_CR13","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1093\/infdis\/jit110","volume":"207","author":"R Paredes","year":"2013","unstructured":"Paredes R, Marconi VC, Lockman S, Abrams EJ, Kuhn L. Impact of Antiretroviral Drugs in Pregnant Women and Their Children in Africa: HIV Resistance and Treatment Outcomes. PMTCT and HIV Resistance in Africa. JID. 2013;207(Suppl 2):S93.","journal-title":"JID"},{"key":"2228_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ijid.2014.12.026","volume":"33","author":"H Ebuy","year":"2015","unstructured":"Ebuy H, Yebyo H, Alemayehu M. Level of adherence and predictors of adherence to the Option B+ PMTCT programme in Tigray, northern Ethiopia. Int J Infect Dis. 2015;33:123\u20139.","journal-title":"Int J Infect Dis"},{"key":"2228_CR15","doi-asserted-by":"crossref","unstructured":"Delelegn Tsegaye, Leul Deribe, Shambel Wodajo. Level of Adherence and Associated Factors to Option B+ PMTCT among Pregnant and Lactating Mothers in Selected Government Health Facilities of South Wollo Zone, Amhara Region, North East Ethiopia. Epidemiology and Health. 2016; Volume: 38, Article ID: e2016043,","DOI":"10.4178\/epih.e2016043"},{"key":"2228_CR16","first-page":"187360","volume":"2015","author":"B Belayihun","year":"2015","unstructured":"Belayihun B, Negus R. Antiretroviral treatment adherence rate and associated factors among people living with HIV in Dubti hospital, Afar regional state, East Ethiopia. Int Sch Res Notices. 2015;2015:187360.","journal-title":"Int Sch Res Notices"},{"key":"2228_CR17","doi-asserted-by":"publisher","first-page":"20662","DOI":"10.7448\/IAS.19.1.20662","volume":"19","author":"I Mitiku","year":"2016","unstructured":"Mitiku I, Arefayne M, Mesfin Y, Gizaw M. Factors associated with loss to follow-up among women in Option B + PMTCT programme in northeast Ethiopia: a retrospective cohort study. J Int AIDS Soc. 2016;19:20662. \n                    https:\/\/doi.org\/10.7448\/IAS.19.1.20662\n                    \n                  .","journal-title":"J Int AIDS Soc"},{"key":"2228_CR18","unstructured":"Haas AD, Msukwa MT, Egger M, et al. Adherence to anterentroviral therapy during and after pregnancy: Cohort study on women recieving care in Malawi's Option B+ program. Clin Infect Dis. 2016;63(9):1227\u201335."},{"key":"2228_CR19","unstructured":"Rational Pharmaceutical Management Plus Program Center for Pharmaceutical Management. Management Sciences for Health, 4301 North Fairfax Drive, Suite 400 Arlington, VA 22203 USA; 2007."},{"key":"2228_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/851810","volume":"2012","author":"SO Ekama","year":"2011","unstructured":"Ekama SO, Herbertson EC, Addeh EJ, Gab-Okafor CV, Onwujekwe DI, Tayo F, et al. Pattern and determinants of antiretroviral drug adherence among Nigerian pregnant women. J Pregnancy. 2011;2012:1\u20137 Hindawi Publishing Corporation.","journal-title":"J Pregnancy"},{"key":"2228_CR21","doi-asserted-by":"publisher","first-page":"e1001015","DOI":"10.1371\/journal.pmed.1001015","volume":"8","author":"T Thomas","year":"2011","unstructured":"Thomas T, Masaba R, Borkowf C, Ndivo R, Zeh C, Misore A, et al. Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding\u2014the Kisumu breastfeeding study, Kenya: a clinical trial. PLoS Med. 2011;8:e1001015.","journal-title":"PLoS Med"},{"key":"2228_CR22","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12884-015-0697-7","volume":"15","author":"S Okawa","year":"2015","unstructured":"Okawa S, Chirwa M, Ishikawa N, et al. Longitudinal adherence to antiretroviral drugs for preventing mother-to-child transmission of HIV in Zambia. BMC Pregnancy Childbirth. 2015;15:258. \n                    https:\/\/doi.org\/10.1186\/s12884-015-0697-7\n                    \n                  .","journal-title":"BMC Pregnancy Childbirth"},{"key":"2228_CR23","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1186\/1471-2458-14-993","volume":"14","author":"H Bailey","year":"2014","unstructured":"Bailey H, Thorne C, Malyuta R, et al. Adherence to antiretroviral therapy during pregnancy and the first year postpartum among HIV-positive women in Ukraine. BMC Public Health. 2014;14:993 \n                    http:\/\/www.biomedcentral.com\/1471-2458\/14\/993\n                    \n                  .","journal-title":"BMC Public Health"},{"key":"2228_CR24","first-page":"320","volume":"3","author":"R Demessie","year":"2014","unstructured":"Demessie R, Mekonnen A, Amogne W, Shibeshi W. Knowledge and adherence to antiretroviral therapy among adult people living with HIV\/AIDS at Tikur Anbessa specialized hospital, Ethiopia. Int J Basic Clin Pharmacol. 2014;3:320\u201330.","journal-title":"Int J Basic Clin Pharmacol"},{"key":"2228_CR25","first-page":"17","volume":"11","author":"SI Bello","year":"2011","unstructured":"Bello SI. HIV\/AIDS patients\u2019 adherence to antiretroviral therapy in Sobi specialist hospital, Ilorin, Nigeria. Glob J Med Res. 2011;11:17\u201325.","journal-title":"Glob J Med Res"},{"key":"2228_CR26","unstructured":"Ng\u2019ambi WF, Tweya H, Speight C, Man-Bourdon C, Hosseinpour M, Phiri S. Determinants of antiretroviral treatment adherence among women accessing PMTCT \u201cOption B+\u201d: a retrospective study at Bwaila Hospital, Malawi. IAS Conference on HIV Pathogenesis, treatment and prevention, 30 June\u201303 July 2013-Kuala Lumpur, Malaysia, MOPE129-Poster Exhibition."},{"key":"2228_CR27","doi-asserted-by":"publisher","first-page":"20919","DOI":"10.7448\/IAS.19.1.20919","volume":"19","author":"L Katirayi","year":"2016","unstructured":"Katirayi L, Namadingo H, Phiri M, et al. HIV-positive pregnant and postpartum women\u2019s perspectives about Option B+ in Malawi: a qualitative study. J Int AIDS Soc. 2016;19:20919. \n                    https:\/\/doi.org\/10.7448\/IAS.19.1.20919\n                    \n                  .","journal-title":"J Int AIDS Soc"},{"issue":"5","key":"2228_CR28","doi-asserted-by":"publisher","first-page":"e35547","DOI":"10.1371\/journal.pone.0035547","volume":"7","author":"SP Wasti","year":"2012","unstructured":"Wasti SP, Simkhada P, Randall J. Factors influencing adherence to antiretroviral treatment in Nepal: a mixed-methods study. PLoS One. 2012;7(5):e35547. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0035547\n                    \n                  .","journal-title":"PLoS One"},{"issue":"11","key":"2228_CR29","doi-asserted-by":"publisher","first-page":"e1002183","DOI":"10.1371\/journal.pmed.1002183","volume":"13","author":"Z Shubber","year":"2016","unstructured":"Shubber Z, Mills EJ, Nachega JB, et al. Patient-reported barriers to adherence to antiretroviral therapy: a systematic review and meta-analysis. PLoS Med. 2016;13(11):e1002183. \n                    https:\/\/doi.org\/10.1371\/journal.pmed.1002183\n                    \n                  .","journal-title":"PLoS Med"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-019-2228-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12884-019-2228-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-019-2228-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T19:18:13Z","timestamp":1582831093000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-019-2228-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,28]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2228"],"URL":"https:\/\/doi.org\/10.1186\/s12884-019-2228-4","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,28]]},"assertion":[{"value":"5 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study obtained ethical approval from Ethical Review Committee (ERC) of Southern Nation Nationalities and Peoples Regional State-Regional Health Bureau (SNNPR-RHB) of Ethiopia. Verbal consent was obtained from each study participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"82"}}